person · Reporting owner
Rudelius Robert James
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PetVivo Holdings, Inc.PETV · Entity 7591 | Director | September 18, 2026 | September 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PetVivo Holdings, Inc.
Report date September 18, 2026 · Filed September 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 406,889 |
Ending reported balance
After 2026-09-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-18 · Grant · Acquired 2,000 · Balance 405,392 F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. Row 2 · 2026-09-18 · Grant · Acquired 1,497 · Balance 406,889 F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions. |
| Common StockSEC Table I · non-derivative | IndirectBy corporation | 21,000 |
Reported balance
Holding disclosure · report date 2026-09-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 21,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the acquisition by the Reporting Person of 2,000 shares and 1,497 shares of PetVivo Holdings, Inc. common stock, for an aggregate of 3,497 shares, through open-market transactions.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Axogen, Inc.
Report date September 30, 2020 · Filed October 01, 2020
Section 16 reporting ended · disclosed 2020-10-01. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 10,000 | $0.30 | $3,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · nonDerivative · entry 4 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 588,615 F4 · shares: Pursuant to entering into a Bridge Promissory Note Conversion Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 3,333 | $0.30 | $999.90 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · nonDerivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 578,615 F3 · shares: Pursuant to exercising the warrants mentioned in explanation 2 above, Mr. Rudelius and John Lai entered into a Stock Transfer Agreement whereby John Lai Transferred 3,333 shares of Common Stock to Mr. Rudelius. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 10,000 | $0.30 | $3,000.00 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 575,282 F2 · shares: Pursuant to entering into a Bridge Promissory Note Agreement, Mr. Rudelius received 10,000 warrants exercisable at $.30 per warrant if exercised on or before December 31, 2018. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 17:09 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 66,667 | $0.30 | $20,000.10 |
DisclosureSEC source: 0001493152-19-000090 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Noble Ventures LLC Disclosed balance after: 565,282 F1 · shares: Mr. Rudelius entered into a Bridge Promissory Note Agreement and subsequently a Bridge Promissory Note Conversion Agreement whereby he converted his $20,000 in outstanding principal and interest into 66,667 shares of Common Stock at a rate of $.30 per share. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 25,861 | $51,722.00 Strike: $0.30 | $1,337,582,642.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · derivative · entry 13 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 25,861 shares Expires 2018-12-31 F5 · derivative.underlying_shares: Pursuant to a Bridge Promissory Note Conversion Agreement, Mr. Rudelius received, and subsequently exercised, 1 warrant for every $2 of the outstanding balance of his Note. The warrants had a strike price of $.30 per warrant, vested immediately, and an expiration date of December 31, 2018. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 25,861 | $51,722.00 Strike: $0.30 | $1,337,582,642.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · derivative · entry 12 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,361 Underlying: Common Stock · 25,861 shares Expires 2018-12-31 F5 · derivative.underlying_shares: Pursuant to a Bridge Promissory Note Conversion Agreement, Mr. Rudelius received, and subsequently exercised, 1 warrant for every $2 of the outstanding balance of his Note. The warrants had a strike price of $.30 per warrant, vested immediately, and an expiration date of December 31, 2018. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 25,000 | $50,000.00 Strike: $0.30 | $1,250,000,000.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · derivative · entry 11 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 25,000 shares Expires 2021-09-24 F2 · derivative.underlying_shares: These warrants were exercised pursuant to a special, one-time Discounted Warrant Exercise Agreement whereby all warrant-holders were given the option to exercise their warrants at $.30 per warrant on or before December 15th, 2018. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 8,621 | $0.30 | $2,586.30 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 8 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498,615 F6 · shares: Pursuant to a Bridge Promissory Note Conversion Agreement, Mr. Rudelius entered into a Stock Transfer Agreement whereby he received 8,621 shares of common stock from John Lai; this number was calculated using a 3-to-1 warrant to share issuance rate (1 share was transferred for every 3 warrants exercised). Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 25,861 | $0.30 | $7,758.30 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 7 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,994 Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 172,406 | $51,722.00 | $8,917,183,132.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 6 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,133 F4 · shares: Pursuant to a Bridge Promissory Note Conversion Agreement, Mr. Rudelius converted $51,721.86 in debt owed to him into 172,406 shares of common stock at a rate of $.30 per share. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 8,333 | $0.30 | $2,499.90 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 5 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,727 F7 · shares: A Stock Transfer Agreement was entered into between John Lai and Robert Rudelius pursuant to entering into the Discounted Warrant Exercise Agreement mentioned in note 2 above and called for the transfer of common stock shares from John Lai to Robert Rudelius in the amount of one-third the amount of warrants exercised pursuant to the Discounted Warrant Exercise Agreement; 8,333 shares were transferred to Robert Rudelius from John Lai pursuant to this agreement. Read SEC document |
| December 11, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 25,000 | $0.30 | $7,500.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 4 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,394 Read SEC document |
| December 10, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 12,500 | Not disclosed Strike: $0.30 | Not disclosed |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · derivative · entry 10 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 12,500 shares Expires 2023-08-20 F1 · price: 100,000 warrants were granted to Robert Rudelius on August 20, 2018 pursuant to his Director Agreement; these warrants vest quarterly over a two-year period in equal tranches of 12,500, have a term of 5 years, and a strike price of $1.00 per warrant. Mr. Rudelius exercised 12,500 warrants that he was granted pursuant to his Director Agreement. F2 · derivative.underlying_shares: These warrants were exercised pursuant to a special, one-time Discounted Warrant Exercise Agreement whereby all warrant-holders were given the option to exercise their warrants at $.30 per warrant on or before December 15th, 2018. Read SEC document |
| December 10, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock Warrant · Derivative | 45,000 | $0.30 Strike: $0.30 | $13,500.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · derivative · entry 9 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 45,000 shares Expires 2020-12-07 F2 · derivative.underlying_shares: These warrants were exercised pursuant to a special, one-time Discounted Warrant Exercise Agreement whereby all warrant-holders were given the option to exercise their warrants at $.30 per warrant on or before December 15th, 2018. Read SEC document |
| December 10, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 19,167 | $0.30 | $5,750.10 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,394 F3 · shares: A Stock Transfer Agreement was entered into between John Lai and Robert Rudelius pursuant to entering into the Discounted Warrant Exercise Agreement mentioned in note 2 above and called for the transfer of common stock shares from John Lai to Robert Rudelius in the amount of one-third the amount of warrants exercised pursuant to the Discounted Warrant Exercise Agreement; 19,167 shares were transferred to Robert Rudelius from John Lai pursuant to this agreement Read SEC document |
| December 10, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 12,500 | $0.30 | $3,750.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,727 Read SEC document |
| December 10, 2018 Filed Dec 28, 2018 22:16 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | OtherCommon Stock | 45,000 | $0.30 | $13,500.00 |
DisclosureSEC source: 0001493152-18-018080 · ownership.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 226,727 Read SEC document |
| September 24, 2018 Filed Oct 4, 2018 18:17 UTC | PetVivo Holdings, Inc. PETV · Entity 7591 | GrantCommon Stock Warrant · Derivative | 25,000 | $50,000.00 Strike: $1.00 | $1,250,000,000.00 |
DisclosureSEC source: 0001493152-18-014079 · ownership.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 25,000 shares Expires 2021-09-24 F1 · derivative.underlying_shares: Warrant for purchase of 25,000 shares of common stock exercisable at $1.00 per share granted on September 24, 2018 in consideration of a bridge note loan to the company in the aggregate amount of $50,000. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 12,000 | $0.00 Strike: $2.75 | $0.00 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · derivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2018-10-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 682 | $48.40 | $33,008.80 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,591 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock. Read SEC document |
| June 08, 2018 Filed Jun 12, 2018 20:42 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 12,000 | $2.75 | $33,000.00 |
DisclosureSEC source: 0001179110-18-008396 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 12,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 11,318 shares of common stock. Read SEC document |
| June 01, 2018 Filed Jun 5, 2018 21:00 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 4,780 | $0.00 Strike: $49.65 | $0.00 |
DisclosureSEC source: 0001179110-18-008092 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,780 Underlying: Common Stock · 4,780 shares Expires 2028-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the earlier of the date of the 2019 annual shareholders meeting or May 31, 2019. Number of shares pursuant to option are based on $120,000 valuation as of the grant date. Read SEC document |
| September 11, 2017 Filed Sep 12, 2017 20:02 UTC | Axogen, Inc. AXGN · Entity 4297 | SaleCommon Stock | 16,143 | $18.00 | $290,574.00 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · nonDerivative · entry 3 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,273 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2017. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionDirector Stock Option (right to purchase) · Derivative | 20,000 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · derivative · entry 4 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2017-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC | Axogen, Inc. AXGN · Entity 4297 | Tax withholdingCommon Stock | 3,857 | $18.15 | $70,004.55 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · nonDerivative · entry 2 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,416 F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 16,143 shares of common stock. Read SEC document |
| September 08, 2017 Filed Sep 12, 2017 20:02 UTC | Axogen, Inc. AXGN · Entity 4297 | Exercise / conversionCommon Stock | 20,000 | $3.50 | $70,000.00 |
DisclosureSEC source: 0001179110-17-012194 · edgar.xml · nonDerivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a cashless exercise. A cashless exercise is a method of exercising a stock option in which the option holder pays the exercise price using shares the reporting person would have received pursuant to the option exercise. As a result of this cashless exercise, the Reporting Person, on a net basis, acquired ownership of an additional 16,143 shares of common stock. Read SEC document |
| June 01, 2017 Filed Jun 5, 2017 20:49 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 15,000 | $0.00 Strike: $14.85 | $0.00 |
DisclosureSEC source: 0001179110-17-008550 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-06-01 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Options vest in equal installments every three months for the first nine months, with the final installment vesting on the date of the then current annual meeting. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:41 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000075 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
| December 29, 2016 Filed Jan 3, 2017 21:41 UTC | Axogen, Inc. AXGN · Entity 4297 | GrantStock Option (right to purchase) · Derivative | 5,000 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0001179110-17-000076 · edgar.xml · derivative · entry 1 Rudelius Robert James · CIK 0001403679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2026-12-29 F1 · derivative.exercise_date: Non-qualified stock option grant for service as Director on Company's Board of directors. Vesting is 100% upon the director's re-election to the Company's Board of Directors at the 2017 Annual Meeting of Shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.